Moloney Securities Asset Management, LLC Merck & Co., Inc. Transaction History

Moloney Securities Asset Management, LLC

$714 Million
Q3 2024

A detailed history of Moloney Securities Asset Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 13,773 shares of MRK stock, worth $1.42 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

13,773

Previous 13,793 0.15%

Holding current value

$1.42 Million

Previous $1.71 Million 8.38%

% of portfolio

0.22%

Previous 0.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$111.15 - $128.97 $2,223 - $2,579	-20 Reduced 0.15%	13,773 $1.56 Million
Q2 2024 Jul 30, 2024	SELL	$123.8 - $132.96 $50,510 - $54,247	-408 Reduced 2.87%	13,793 $1.71 Million
Q1 2024 May 01, 2024	SELL	$113.24 - $131.95 $57,072 - $66,502	-504 Reduced 3.43%	14,201 $1.87 Million
Q4 2023 Jan 30, 2024	SELL	$100.18 - $109.02 $25,746 - $28,018	-257 Reduced 1.72%	14,705 $1.6 Million
Q3 2023 Oct 31, 2023	SELL	$102.95 - $114.33 $59,093 - $65,625	-574 Reduced 3.69%	14,962 $1.54 Million
Q2 2023 Jul 31, 2023	SELL	$108.61 - $118.38 $91,558 - $99,794	-843 Reduced 5.15%	15,536 $1.79 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $382,730 - $427,049	-3,718 Reduced 18.5%	16,379 $1.74 Million
Q4 2022 Jan 30, 2023	BUY	$87.44 - $112.11 $135,619 - $173,882	1,551 Added 8.36%	20,097 $2.23 Million
Q3 2022 Oct 31, 2022	SELL	$84.53 - $94.96 $25,866 - $29,057	-306 Reduced 1.62%	18,546 $1.6 Million
Q2 2022 Aug 03, 2022	BUY	$83.49 - $94.64 $54,268 - $61,516	650 Added 3.57%	18,852 $1.72 Million
Q1 2022 May 10, 2022	BUY	$73.51 - $82.4 $50,280 - $56,361	684 Added 3.9%	18,202 $1.49 Million
Q4 2021 Jan 28, 2022	SELL	$72.28 - $90.54 $117,888 - $147,670	-1,631 Reduced 8.52%	17,518 $1.34 Million
Q3 2021 Oct 27, 2021	BUY	$71.68 - $78.83 $7,383 - $8,119	103 Added 0.54%	19,149 $1.44 Million
Q2 2021 Jul 26, 2021	SELL	$70.31 - $77.77 $87,957 - $97,290	-1,251 Reduced 6.16%	19,046 $1.48 Million
Q1 2021 Apr 28, 2021	SELL	$68.86 - $81.11 $1.21 Million - $1.42 Million	-17,565 Reduced 46.39%	20,297 $1.57 Million
Q4 2020 Feb 08, 2021	SELL	$71.77 - $79.65 $71,770 - $79,650	-1,000 Reduced 2.57%	37,862 $3.1 Million
Q3 2020 Oct 20, 2020	SELL	$73.18 - $82.95 $444,056 - $503,340	-6,068 Reduced 13.51%	38,862 $3.22 Million
Q2 2020 Jul 31, 2020	BUY	$70.42 - $80.13 $86,053 - $97,918	1,222 Added 2.8%	44,930 $3.47 Million
Q1 2020 May 08, 2020	BUY	$63.36 - $87.82 $438,387 - $607,626	6,919 Added 18.81%	43,708 $3.36 Million
Q4 2019 Feb 06, 2020	BUY	$77.58 - $87.54 $130,644 - $147,417	1,684 Added 4.8%	36,789 $3.35 Million
Q3 2019 Nov 01, 2019	SELL	$76.08 - $82.93 $435,558 - $474,774	-5,725 Reduced 14.02%	35,105 $2.96 Million
Q2 2019 Jul 29, 2019	BUY	$69.84 - $81.59 $75,008 - $87,627	1,074 Added 2.7%	40,830 $3.42 Million
Q1 2019 May 03, 2019	SELL	$69.58 - $79.36 $141,943 - $161,894	-2,040 Reduced 4.88%	39,756 $3.31 Million
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $25,052 - $29,072	-384 Reduced 0.91%	41,796 $3.19 Million
Q3 2018 Oct 24, 2018	SELL	$57.69 - $67.84 $17,133 - $20,148	-297 Reduced 0.7%	42,180 $0
Q2 2018 Jul 26, 2018	SELL	$50.83 - $59.72 $124,736 - $146,552	-2,454 Reduced 5.46%	42,477 $2.58 Million
Q1 2018 Apr 25, 2018	BUY	$50.96 - $59.23 $90,199 - $104,837	1,770 Added 4.1%	44,931 $2.45 Million
Q4 2017 Jan 25, 2018	BUY	$51.62 - $61.64 $295,989 - $353,443	5,734 Added 15.32%	43,161 $2.43 Million
Q3 2017 Oct 18, 2017	BUY	$58.67 - $63.13 $2.2 Million - $2.36 Million	37,427	37,427 $2.4 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.

Account

Moloney Securities Asset Management, LLC Merck & Co., Inc. Transaction History